BioCatalystWatch
TLXWorkspace / TLX / OverviewCompany library
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd

Telix Pharmaceuticals Ltd (TLX)

Website

Price
Market cap
Next catalystExpected 2026TLX090-Tx — SOLACE · Enrollment completionCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

LAT1

Upcoming / outlook

  • Timing and evidence

PSMA

Upcoming / outlook

  • Timing and evidence

PSMA

Upcoming / outlook

225Ac-TLX592-Tx — AlphaPRO

PSMA

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

TLX593-Px

PSMA

PreINDP1P2P3FilingApproved
Upcoming / outlook

CAIX

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

CAIX

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

225Ac-TLX592-Tx — AlphaPRO

PSMA

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

PSMA

Upcoming / outlook

  • Timing and evidence

TLX593-Px

PSMA

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

LAT1

PreINDP1P2P3FilingApproved
Upcoming / outlook

LAT1

TLX597-Tx — OPTIMAL-e

PSMA

PreINDP1P2P3FilingApproved
olaratumab

PDGFRα

PreINDP1P2P3FilingApproved

olaratumab

PDGFRα

PreINDP1P2P3FilingApproved
olaratumab

PDGFRα

PreINDP1P2P3FilingApproved

PSMA

Partner / License out

CD66

PreINDP1P2P3FilingApproved

CD66

PreINDP1P2P3FilingApproved

CD66

CD66

Approved / commercial

Approved / commercial

PSMA

Approved

PreINDP1P2P3FilingApproved

LAT1

History / paused

LAT1

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

TLX PR & News

PR & News

TLX SEC archive